1. Home
  2. AZTR vs CNSP Comparison

AZTR vs CNSP Comparison

Compare AZTR & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • CNSP
  • Stock Information
  • Founded
  • AZTR 2014
  • CNSP 2017
  • Country
  • AZTR United States
  • CNSP United States
  • Employees
  • AZTR N/A
  • CNSP N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • AZTR Health Care
  • CNSP Health Care
  • Exchange
  • AZTR Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • AZTR 5.2M
  • CNSP 5.6M
  • IPO Year
  • AZTR 2023
  • CNSP 2019
  • Fundamental
  • Price
  • AZTR $0.30
  • CNSP $1.25
  • Analyst Decision
  • AZTR
  • CNSP Hold
  • Analyst Count
  • AZTR 0
  • CNSP 1
  • Target Price
  • AZTR N/A
  • CNSP N/A
  • AVG Volume (30 Days)
  • AZTR 280.4K
  • CNSP 332.7K
  • Earning Date
  • AZTR 05-08-2025
  • CNSP 05-14-2025
  • Dividend Yield
  • AZTR N/A
  • CNSP N/A
  • EPS Growth
  • AZTR N/A
  • CNSP N/A
  • EPS
  • AZTR N/A
  • CNSP N/A
  • Revenue
  • AZTR $7,500.00
  • CNSP N/A
  • Revenue This Year
  • AZTR N/A
  • CNSP N/A
  • Revenue Next Year
  • AZTR N/A
  • CNSP N/A
  • P/E Ratio
  • AZTR N/A
  • CNSP N/A
  • Revenue Growth
  • AZTR N/A
  • CNSP N/A
  • 52 Week Low
  • AZTR $0.23
  • CNSP $1.21
  • 52 Week High
  • AZTR $12.00
  • CNSP $800.00
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 39.89
  • CNSP 30.28
  • Support Level
  • AZTR $0.28
  • CNSP $1.28
  • Resistance Level
  • AZTR $0.35
  • CNSP $1.46
  • Average True Range (ATR)
  • AZTR 0.03
  • CNSP 0.38
  • MACD
  • AZTR -0.00
  • CNSP -0.12
  • Stochastic Oscillator
  • AZTR 34.45
  • CNSP 1.18

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: